文献速递妇科生殖医学

卵巢子宫内膜异位囊肿存在时抗苗勒管激素降低:一项系统综述与荟萃分析

Antimüllerian hormone is reduced in the presence of ovarian endometriomas: a systematic review and meta-analysis.
PubMed 文献 · Fertil Steril · 2018-01-01

本系统综述与荟萃分析纳入17项研究共968例卵巢子宫内膜异位囊肿患者和1874例无子宫内膜异位囊肿对照,评估未手术子宫内膜异位囊肿对血清抗苗勒管激素(AMH)水平的影响。结果显示子宫内膜异位囊肿患者AMH显著低于无子宫内膜异位囊肿者(均数差-0.84,95%CI -1.16至-0.52),也低于非子宫内膜异位良性卵巢囊肿患者(均数差-0.85,95%CI -1.37至-0.32)和健康卵巢女性(均数差-0.61,95%CI -0.99至-0.24)。

要点

  • 未手术卵巢子宫内膜异位囊肿患者AMH显著低于无子宫内膜异位囊肿者,均数差-0.84(95%CI -1.16至-0.52)。
  • 子宫内膜异位囊肿患者AMH显著低于非子宫内膜异位良性卵巢囊肿患者,均数差-0.85(95%CI -1.37至-0.32)。
  • 子宫内膜异位囊肿患者AMH显著低于健康卵巢女性,均数差-0.61(95%CI -0.99至-0.24)。

核心结论

  • 以AMH评估的卵巢储备在卵巢子宫内膜异位囊肿患者中较其他良性卵巢囊肿患者和健康卵巢女性均降低。

研究设计与样本

  • 系统综述与荟萃分析,检索电子数据库至2017年6月,纳入17项研究,共968例子宫内膜异位囊肿患者和1874例无子宫内膜异位囊肿对照。

主要发现

  • 未手术子宫内膜异位囊肿患者AMH显著低于无子宫内膜异位囊肿者,均数差-0.84(95%CI -1.16至-0.52)。
  • 子宫内膜异位囊肿患者AMH显著低于非子宫内膜异位良性卵巢囊肿患者,均数差-0.85(95%CI -1.37至-0.32)。
  • 子宫内膜异位囊肿患者AMH显著低于健康卵巢女性,均数差-0.61(95%CI -0.99至-0.24)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate if the presence of endometriomas impacts on the ovarian reserve as evaluated with antimüllerian hormone (AMH). DESIGN: Systematic review and meta-analysis. SETTING: Not applicable. PATIENT(S): Patients with unoperated endometriomas versus controls without endometriomas. INTERVENTION(S): Electronic databases searched up to June 2017 to identify articles evaluating AMH levels in patients with unoperated endometriomas versus controls without endometriomas. MAIN OUTCOME MEASURE(S): The primary analysis was aimed at evaluation of AMH levels (mean and SD) in patients with and without endometriomas. Secondary analyses were aimed at evaluating AMH levels in patients with ovarian endometriomas compared to patients with either non-endometriosis benign ovarian cysts or healthy ovaries. RESULT(S): Of the 39 studies evaluated in detail, 17 were included, for a total of 968 patients with endometriomas and 1874 without endometriomas. AMH was significantly lower in patients with unoperated endometriomas compared to patients with no endometriomas (mean difference -0.84, with 95% confidence interval [CI] -1.16 to -0.52). At secondary analyses, AMH in patients with endometriomas was significantly lower both versus non-endometriosis benign ovarian cysts (mean difference -0.85, 95% CI -1.37 to -0.32, and versus women with healthy ovaries (mean difference -0.61, 95% CI -0.99 to -0.24). CONCLUSION(S): Ovarian reserve evaluated with AMH is reduced in patients with ovarian endometriomas compared both to patients with other benign ovarian cysts, and to patients with healthy ovaries.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Muzii L, Di Tucci C, Di Feliciantonio M, et al. Antimüllerian hormone is reduced in the presence of ovarian endometriomas: a systematic review and meta-analysis. Fertil Steril. 2018. PMID: 30316440. doi:10.1016/j.fertnstert.2018.06.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。